September 4, 2025 – TheNewswire - Vancouver, British Columbia, Orion Nutraceuticals Inc. (the “Company”) is pleased to announce that, effective Tuesday, September 9, 2025, the Company will be changing its name from Orion Nutraceuticals Inc. to Pinetree Ventures Corp. (the “Name Change”) and completing a share consolidation (the “Consolidation”).

 

Under the Consolidation, all of the Company’s issued and outstanding common shares (“Shares”) will be consolidated on the basis of one (1) post-Consolidation Share for each twenty-five (25) pre-Consolidation Shares.

 

Following the Consolidation, the number of issued and outstanding Shares will be reduced from 29,307,965 pre-Consolidation Shares to approximately 1,172,318 post-Consolidation Shares, each without par value. The exercise and conversion prices of the Company’s outstanding warrants and stock options, as well as the number of Shares issuable thereunder, will be proportionately adjusted in accordance with the terms of the Consolidation.

 

The new CUSIP number for the Shares will be 723328209 and the new ISIN number will be CA7233282093.  

 

No fractional Shares will be issued in connection with the Consolidation. Any fractions of Shares will be rounded down to the nearest whole Share, and no cash consideration will be paid in lieu of fractional Shares.

 

The Company is actively reviewing and assessing investment opportunities across multiple sectors to enhance shareholder value.

 

On behalf of the Board of Directors of:

 

Orion Nutraceuticals Inc.

Guy Bourgeois, Director
Tel: (604) 687-2038

 

Information set forth in this press release may involve forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company’s expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the need for additional financing; reliance on key personnel; and the potential for conflicts of interest among certain officers or directors with certain other projects. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. For further information on risk, investors are advised to see the Company’s MD&A and other disclosure filings with the regulators which are found at www.sedarplus.ca.